Literature DB >> 19551545

Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.

Heiichiro Udono1, Tomoko Ichiyanagi, Shusaku Mizukami, Takashi Imai.   

Abstract

Heat shock proteins (HSP) are molecular chaperones implicated in facilitation of protein folding and translocation between distinct compartments, and hence in preventing protein from aggregation. In terms of proteolysis, HSP act as a double-edged sword, stimulating proteasome-dependent proteolysis while preventing the degradation of the same proteins, even though in both cases association of unfolded proteins with HSP is the initial step. The proteasomal degradation products are utilised as ligands of major histocompatibility complex (MHC) class I molecules to be recognised by CD8(+) T cells, leading to activation of cytotoxic T cell immunity indispensable in fighting virus infections and cancers. In this context, HSP-mediated antigen traffic towards proteasomal degradation is coupled with acquired T cell immunity. In addition, exogenous antigens internalised by dendritic cells (DC) are also forwarded to the proteasome, possibly through the ER-associated degradation (ERAD) system, based on the fusion of the ER-membrane to the endosome containing the antigens. Thus, antigens within endosomes might be translocated to the cytosol, possibly through the Sec61 complex recruited from ER and degraded by the proteasome, rendering their peptides presentable by MHC class I molecules, a process known as cross-presentation. Since binding protein (Bip) facilitates degradation of most ER luminal soluble proteins in yeast, it is possible that endosomal HSP in DC, mimicking the action of Bip, facilitate the degradation of internalised soluble antigens. This may explain why the HSP-peptide/protein complex is extremely efficient in terms of cross-presentation ability. In this review, we discuss how HSP are linked to the ubiquitin-dependent proteasome system to generate peptides presentable by MHC molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551545     DOI: 10.3109/02656730902902183

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  5 in total

Review 1.  Heat shock proteins in multiple myeloma.

Authors:  Lei Zhang; Jacqueline H L Fok; Faith E Davies
Journal:  Oncotarget       Date:  2014-03-15

Review 2.  Heat Shock Proteins 90 kDa: Immunomodulators and Adjuvants in Vaccine Design Against Infectious Diseases.

Authors:  Mariana G Corigliano; Valeria A Sander; Edwin F Sánchez López; Víctor A Ramos Duarte; Luisa F Mendoza Morales; Sergio O Angel; Marina Clemente
Journal:  Front Bioeng Biotechnol       Date:  2021-01-20

3.  In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses.

Authors:  Matin Kayyal; Azam Bolhassani; Zahra Noormohammadi; Majid Sadeghizadeh
Journal:  Mol Biotechnol       Date:  2021-07-25       Impact factor: 2.695

4.  Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets.

Authors:  Rodrigo Carlini Fernando; Fabricio de Carvalho; Diego Robles Mazzotti; Adriane Feijó Evangelista; Walter Moisés Tobias Braga; Maria de Lourdes Chauffaille; Adriana Franco Paes Leme; Gisele Wally Braga Colleoni
Journal:  Genes Cancer       Date:  2015-11

5.  Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6.

Authors:  Arcangelo Liso; Stefano Castellani; Francesca Massenzio; Rosa Trotta; Alessandra Pucciarini; Barbara Bigerna; Pasquale De Luca; Pietro Zoppoli; Filippo Castiglione; Maria Concetta Palumbo; Fabrizio Stracci; Matteo Landriscina; Giorgina Specchia; Leon A Bach; Massimo Conese; Brunangelo Falini
Journal:  Oncotarget       Date:  2017-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.